← 產業報告目錄

Digital Twins in Healthcare Market By Component (Software, Services), Application (Personalized Medicine, Drug Discovery, Medical Education, Workflow Optimization), End User (Providers, Research & Academia, Payers), and Region - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-04-22頁數 275報告編號 HIT8675

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global digital twin healthcare market is experiencing significant growth in 2025, driven by the increasing adoption of digital twins in healthcare and rising investments by public & private entities. The market is projected to reach USD 101.19 billion by 2031 from USD 7.47 billion in 2026, at a CAGR of 68.4% during the forecast period. There have been many investments in digital twins by both public and private organizations due to their innovation potential. For instance, Quibim, based in Valencia, is developing the use of imaging biomarkers in precision medicine. Quibim has made an announcement on its successful raising of funds amounting to USD 50.6 million as part of its series A investment round to establish a footprint in the USA market. According to Quibim, this will be a milestone in developing human digital twins. These are dynamic models that will make it possible to monitor the well-being of people while ensuring that drugs are developed efficiently. “Surgical planning & medical education segment accounted for the second-largest share of the market during the forecast period, by application.” In 2025, the surgical planning & medical education segment accounted for the second-largest share of the digital twin in the healthcare market. The growth in this market was driven by the ability of digital twins to work with virtual reality applications that enable the residents to train by simulating surgical processes for the specific anatomical and physiological profile of the patients. This helps in generating a real-life performance depiction and facilitates the evaluation of the intraoperative metrics. Many companies have simulated human anatomy and surgery processes in order to reduce reliance on cadavers. “By component, software accounted for the fastest growth during the forecast period.” Based on component, software is projected to witness the fastest growth in the digital twins in healthcare market during the forecast period. The reason behind such growth is associated with the rising number of adoptions of digital twin platforms in order to offer real-time simulation and predictive analytics. In particular, healthcare organizations and research institutions will start relying on software digital twin solutions to develop virtual models of patients, organs, and healthcare facilities based on information collected via imaging techniques, electronic health records, and wearable connected devices. Software digital twin solutions enable not only continuous monitoring but also predicting disease progression and creating personalized treatment plans. Rising interest in digital twin technology and software solutions is also explained by the growing adoption of platforms based on AI and cloud computing. In addition, the rising trend towards value-based care and precision medicine is anticipated to boost demand for digital twin software solutions. Furthermore, the ongoing investments in digital health solutions and the necessity of building interoperable systems capable of interacting with the IT infrastructures of hospitals contribute to such growth. “Asia Pacific to witness the highest growth rate during the forecast period.” The market for digital twins in healthcare in the Asia Pacific region is growing at a fast pace, owing to increased clinical research activities and the adoption of digital technologies by healthcare providers. Asia Pacific has emerged as one of the major hubs for research activities, where countries like India, Japan, South Korea, and Australia have become prominent owing to improved regulation and lower cost structure. Pharmaceutical and biotechnology companies are increasingly engaging in research initiatives through the use of data and simulations, which is further driving the adoption of digital twin technologies. At the same time, significant investment is being made towards the development of digital health infrastructure in the form of artificial intelligence, cloud computing, and health IT systems, which are vital for the implementation of digital twin technologies. Furthermore, governments in the Asia Pacific region are working towards the digitalization of the healthcare industry to improve efficiency and performance. There have been recent developments in this regard. For example, the Japanese company Fujitsu Limited has developed digital twin technology in the healthcare sector using artificial intelligence-based simulation platforms for personalized medicine and decision-making in clinical processes. The breakdown of primary participants is as follows: • By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25% • By Designation - C-level: 42%, Director-level: 31%, and Others: 27% • By Region - North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%. The key players operating in the digital twin in healthcare market include Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France). • The study includes an in-depth competitive analysis of these key players in the digital twin in healthcare market, with their company profiles, recent developments, and key market strategies. Research Coverage The report analyzes the digital twins in healthcare market and aims to estimate the market size and future growth potential of various market segments, based on components, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies. Reasons to buy this report This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market. This report provides insights into:  Analysis of key drivers (increasing Investments in digital twins in developed as well as emerging technology adoption, rising demand for personalized medicine, increasing funding and investments in digital twin startups), restraints (accuracy and privacy issues with digital twin systems and high implementation costs), opportunities (growing importance of digital twin Iin emerging market, increasing focus on cutting edge real-time data analytics), and challenges (lack of technical expertise & data management issues) influencing the growth of the digital twin market  Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the digital twins in healthcare market  Market Development: Comprehensive information on the lucrative emerging markets, components, applications, end users, and regions  Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the digital twins in healthcare market  Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the digital twins in healthcare market like Microsoft Corporation (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Amazon Web Services, Inc. (US), Dassault Systèmes (France), GE Healthcare (US), IBM (US), NVIDIA Corporation (US), Oracle Corporation (US), PTC (US), SAP (Germany), Atos SE (France), ANSYS, Inc. (US), Faststream Technologies (US), Rescale, Inc. (US), Twin Health (US), NUREA (France), Predictiv (US), Verto (Canada), Qbio (US), Virtonomy GmbH (Germany), Unlearn.ai, Inc. (US), ThoughtWire (Canada), Sim and Cure (France), and PrediSurge (France)
目錄 Table of Contents
1 INTRODUCTION 27 1.1 STUDY OBJECTIVES 27 1.2 MARKET DEFINITION 27 1.3 STUDY SCOPE 28 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 28 1.3.2 INCLUSIONS & EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 29 1.3.4 CURRENCY CONSIDERED 29 1.4 STAKEHOLDERS 30 1.5 SUMMARY OF CHANGES 30 2 EXECUTIVE SUMMARY 31 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 31 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 32 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET 33 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 34 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 35 3 PREMIUM INSIGHTS 36 3.1 DIGITAL TWINS IN HEALTHCARE MARKET OVERVIEW 36 3.2 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT & REGION 37 3.3 DIGITAL TWINS IN HEALTHCARE MARKET: REGIONAL SNAPSHOT 37 4 MARKET OVERVIEW 38 4.1 INTRODUCTION 38 4.2 MARKET DYNAMICS 39 4.2.1 DRIVERS 39 4.2.1.1 Increasing investments by public and private entities 39 4.2.1.2 Growing applications of digital twins 40 4.2.1.3 Technological advancements 40 4.2.1.4 Growing funding and investments in digital twin startups 41 4.2.2 RESTRAINTS 41 4.2.2.1 Managing data quality, privacy issues, and high implementation costs 41 4.2.3 OPPORTUNITIES 42 4.2.3.1 Increasing focus on cutting-edge real-time data analytics 42 4.2.3.2 Growing importance of digital twins in emerging economies 42   4.2.4 CHALLENGES 43 4.2.4.1 Lack of skilled professionals 43 4.2.4.2 Integration with existing systems and outdated digital infrastructure 43 4.3 UNMET NEEDS AND WHITE SPACES 44 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 44 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 45 5 INDUSTRY TRENDS 46 5.1 PORTER’S FIVE FORCES ANALYSIS 46 5.1.1 INTENSITY OF COMPETITIVE RIVALRY (HIGH) 47 5.1.2 BARGAINING POWER OF SUPPLIERS (LOW) 47 5.1.3 BARGAINING POWER OF BUYERS (HIGH) 47 5.1.4 THREAT OF NEW ENTRANTS (LOW) 48 5.1.5 THREAT OF SUBSTITUTES (LOW) 48 5.2 MACROECONOMIC INDICATORS 48 5.2.1 INTRODUCTION 48 5.2.2 GDP TRENDS AND FORECAST 48 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 49 5.3 VALUE CHAIN ANALYSIS 49 5.3.1 RESEARCH & PRODUCT DEVELOPMENT 50 5.3.2 TECHNOLOGY INPUTS AND INFRASTRUCTURE 51 5.3.3 PLATFORM DEVELOPMENT AND INTEGRATION 51 5.3.4 DISTRIBUTION 51 5.3.5 MARKETING AND SALES 51 5.3.6 POST-SALE SERVICES 51 5.4 ECOSYSTEM ANALYSIS 51 5.5 PRICING ANALYSIS 53 5.5.1 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY TYPE (2025) 53 5.5.2 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY REGION (2025) 54 5.6 KEY CONFERENCES AND EVENTS, 2026–2027 55 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55 5.8 INVESTMENT AND FUNDING SCENARIO 56 5.9 CASE STUDY ANALYSIS 57 5.10 IMPACT OF 2025 US TARIFF – DIGITAL TWIN IN HEALTHCARE MARKET 58 5.10.1 INTRODUCTION 58 5.10.2 KEY TARIFF RATES 59 5.10.3 PRICE IMPACT ANALYSIS 59 5.10.4 IMPACT ON COUNTRY/REGION 60 5.10.4.1 US 60 5.10.4.2 Europe 60 5.10.4.3 Asia Pacific 61 5.10.5 IMPACT ON END USERS 61 5.10.5.1 Pharma & biopharma companies 61 5.10.5.2 Research & academia 61 5.10.5.3 Healthcare providers 62 5.10.5.4 Medical device companies 62 5.10.5.5 Other end users 62 6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 63 6.1 KEY EMERGING TECHNOLOGIES 63 6.1.1 AI/ML AND SIMULATION MODELS 63 6.1.2 CLOUD COMPUTING AND HIGH-PERFORMANCE COMPUTING 64 6.1.3 DATA INTEGRATION PLATFORMS 64 6.2 COMPLEMENTARY TECHNOLOGIES 64 6.2.1 INTERNET OF MEDICAL THINGS (IOMT) AND CONNECTED DEVICES 65 6.2.2 MEDICAL IMAGING AND IMAGING AI 65 6.3 ADJACENT TECHNOLOGIES 65 6.3.1 CLINICAL DECISION SUPPORT SYSTEMS 66 6.3.2 AR/VR FOR SURGICAL SIMULATION AND TRAINING 66 6.4 TECHNOLOGY/PRODUCT ROADMAP 66 6.5 PATENT ANALYSIS 67 6.5.1 PATENT PUBLICATION TRENDS FOR DIGITAL TWIN IN HEALTHCARE MARKET 67 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 68 6.6 FUTURE APPLICATIONS 70 6.6.1 AI-DRIVEN PREDICTIVE MODELING AND CLINICAL DECISION SUPPORT 70 6.6.2 VIRTUAL THERAPEUTIC SIMULATION AND PERSONALIZED INTERVENTIONS 70 6.6.3 VIRTUAL CLINICAL TRIALS AND HEALTH SYSTEM OPTIMIZATION 71 6.6.4 POPULATION HEALTH MANAGEMENT AND PANDEMIC RESPONSE MODELING 71 6.7 IMPACT OF AI/GEN AI ON DIGITAL TWIN IN HEALTHCARE MARKET 71 6.7.1 INTRODUCTION 71 6.7.2 MARKET POTENTIAL OF AI/GEN AI IN DIGITAL TWIN IN HEALTHCARE MARKET 72 6.7.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 73 6.7.3.1 AI-driven cardiac digital twin for personalized treatment planning 73 6.7.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 74 6.7.4.1 Digital twin analytics & AI-driven simulation platforms 74 6.7.4.2 Digital twin platform integration & regulatory infrastructure 74 6.7.4.3 Clinical care, virtual monitoring & personalized therapeutics 75 6.7.5 USER READINESS AND IMPACT ASSESSMENT 75 6.7.5.1 User readiness 75 6.7.5.1.1 User A: Pharma & biopharma companies 75 6.7.5.1.2 User B: Research & academia 75 6.7.5.2 Impact assessment 76 6.7.5.2.1 User A: Pharma & biopharma companies 76 6.7.5.2.2 User B: Research & academia 76 7 REGULATORY LANDSCAPE 77 7.1 REGIONAL REGULATIONS AND COMPLIANCE 77 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 7.1.2 REGULATORY FRAMEWORK 80 7.1.2.1 North America 80 7.1.2.2 Europe 81 7.1.2.3 Asia Pacific 81 7.1.2.4 Latin America 82 7.1.2.5 Middle East & Africa 82 7.1.3 INDUSTRY STANDARDS 82 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 84 8.1 INTRODUCTION 84 8.2 DECISION-MAKING PROCESS 84 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 84 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 85 8.3.2 BUYING CRITERIA 86 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 87 8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 87 8.5.1 UNMET NEEDS 87 8.5.2 END USER EXPECTATIONS 89 8.6 MARKET PROFITABILITY 89 9 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT 91 9.1 INTRODUCTION 92 9.2 SERVICES 92 9.2.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES 92 9.3 SOFTWARE 93 9.3.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH 93 10 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE 95 10.1 INTRODUCTION 96 10.2 PROCESS TWINS 96 10.2.1 RISING DEMAND FOR HEALTHCARE WORKFLOWS AND OPERATIONAL PROCESSES TO BOOST ADOPTION 96 10.3 SYSTEM TWINS 97 10.3.1 INCREASED DEMAND FOR OPERATIONAL EFFICIENCY IN HOSPITALS TO BOOST SEGMENT 97 10.4 WHOLE BODY TWINS 98 10.4.1 ADVANCEMENTS IN AI AND ML TECHNOLOGIES TO BOOST MARKET 98 10.5 BODY PART TWINS 99 10.5.1 RISING DEMAND FOR PERSONALIZED & PRECISION MEDICINE TO FUEL MARKET GROWTH 99 11 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION 101 11.1 INTRODUCTION 102 11.2 DRUG DISCOVERY & DEVELOPMENT 102 11.2.1 ABILITY OF DIGITAL TWINS TO ENHANCE DRUG DISCOVERY & DEVELOPMENT TO BOOST MARKET 102 11.3 PERSONALIZED MEDICINE 103 11.3.1 QUICK AND COST-EFFECTIVE DEVELOPMENT AND TESTING OF PERSONALIZED DIAGNOSTICS TO SUPPORT MARKET 103 11.4 SURGICAL PLANNING & MEDICAL EDUCATION 104 11.4.1 ABILITY TO ENHANCE SURGICAL TRAINING AND SIMULATE SURGICAL PROCEDURES TO BOOST ADOPTION 104 11.5 MEDICAL DEVICE DESIGN & TESTING 105 11.5.1 POTENTIAL OF DIGITAL TWINS TO STREAMLINE OPERATIONS, MINIMIZE RISK, AND REDUCE DOWNTIME TO PROMOTE USE 105 11.6 HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT 106 11.6.1 IMPROVED EFFICIENCY AND VALUABLE INSIGHTS TO SUPPORT DEMAND 106 11.7 OTHER APPLICATIONS 107 12 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER 109 12.1 INTRODUCTION 110 12.2 PHARMA & BIOPHARMA COMPANIES 110 12.2.1 RISING DEMAND TO REDUCE TIME AND COST OF DRUG DEVELOPMENT TO BOOST ADOPTION 110 12.3 RESEARCH & ACADEMIA 111 12.3.1 INTERACTIVE AND IMMERSIVE LEARNING EXPERIENCES OFFERED BY DIGITAL TWINS TO BOOST ADOPTION 111 12.4 HEALTHCARE PROVIDERS 112 12.4.1 LOWER COSTS AND BETTER PATIENT TREATMENT TO FAVOR MARKET GROWTH 112 12.5 MEDICAL DEVICE COMPANIES 113 12.5.1 GROWING USE OF DIGITAL TWINS FOR SOFTWARE OPTIMIZATION OF MEDICAL DEVICES TO FUEL GROWTH 113 12.6 OTHER END USERS 114   13 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION 116 13.1 INTRODUCTION 117 13.2 NORTH AMERICA 117 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 118 13.2.2 US 120 13.2.2.1 Expanding applications of digital twins in healthcare to bolster market growth 120 13.2.3 CANADA 123 13.2.3.1 National digital health strategy and AI-driven clinical research accelerating adoption 123 13.3 EUROPE 125 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 126 13.3.2 GERMANY 128 13.3.2.1 Hospital digitalization mandates and engineering-healthcare convergence drive market 128 13.3.3 UK 130 13.3.3.1 NHS digital transformation and in silico trial leadership advances digital twin market 130 13.3.4 FRANCE 133 13.3.4.1 National AI health strategy and clinical research infrastructure support digital twin integration 133 13.3.5 ITALY 135 13.3.5.1 National recovery plan investments and clinical research modernization drive adoption 135 13.3.6 SPAIN 137 13.3.6.1 Health system digital transformation and biomedical research network enables digital twin growth 137 13.3.7 REST OF EUROPE 139 13.4 ASIA PACIFIC 141 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 142 13.4.2 JAPAN 144 13.4.2.1 National Digital Health Mission and pharma innovation ecosystem emerging as digital twin growth frontier 144 13.4.3 CHINA 147 13.4.3.1 National AI strategy and smart hospital infrastructure to drive large-scale digital twin deployment 147 13.4.4 INDIA 149 13.4.4.1 Improvement in healthcare infrastructure to support market growth 149 13.4.5 AUSTRALIA 151 13.4.5.1 National Digital Health Strategy 2023–2028 and Medical Research Future Fund advance digital twin adoption 151 13.4.6 SOUTH KOREA 153 13.4.6.1 Smart Hospital Policy and deep tech industrial ecosystem position country as regional leader 153 13.4.7 REST OF ASIA PACIFIC 155 13.5 LATIN AMERICA 157 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 158 13.5.2 BRAZIL 160 13.5.2.1 Country to dominate regional market 160 13.5.3 MEXICO 162 13.5.3.1 Favorable government strategies to drive market growth 162 13.5.4 REST OF LATIN AMERICA 164 13.6 MIDDLE EAST & AFRICA 166 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 167 13.6.2 GCC COUNTRIES 169 13.6.2.1 Increasing healthcare infrastructure development and investment to support market growth 169 13.6.2.2 Saudi Arabia 171 13.6.2.2.1 Government-led digital transformation and strong investments in AI-driven healthcare 171 13.6.2.3 UAE 173 13.6.2.3.1 Advancing digital health innovation and strategic collaborations to drive digital biomarkers adoption 173 13.6.2.4 Other GCC countries 175 13.6.2.4.1 Regulatory initiatives, national health visions, and digital health infrastructure driving digital biomarkers adoption 175 13.6.3 SOUTH AFRICA 177 13.6.3.1 Rising healthcare demand and need for cost-efficient, data-driven care delivery drive adoption 177 13.6.4 REST OF MIDDLE EAST & AFRICA 179 14 COMPETITIVE LANDSCAPE 182 14.1 OVERVIEW 182 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 182 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET 182 14.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 184 14.4 MARKET SHARE ANALYSIS, 2025 185 14.5 BRAND/PRODUCT COMPARISON 188 14.6 VALUATION & FINANCIAL METRICS 189 14.6.1 FINANCIAL METRICS 189 14.6.2 COMPANY VALUATION 189 14.7 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2025 190 14.7.1 STARS 190 14.7.2 EMERGING LEADERS 190 14.7.3 PERVASIVE PLAYERS 190 14.7.4 PARTICIPANTS 190   14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 192 14.7.5.1 Company footprint 192 14.7.5.2 Region footprint 192 14.7.5.3 Component footprint 193 14.7.5.4 Type footprint 194 14.7.5.5 Application footprint 194 14.7.5.6 End user footprint 195 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 196 14.8.1 PROGRESSIVE COMPANIES 196 14.8.2 RESPONSIVE COMPANIES 196 14.8.3 DYNAMIC COMPANIES 196 14.8.4 STARTING BLOCKS 196 14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 197 14.8.5.1 Detailed list of key startups/SME players 197 14.8.5.2 Competitive benchmarking of key startups/SMEs 198 14.9 COMPETITIVE SCENARIO 199 14.9.1 PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS 199 14.9.2 DEALS 200 14.9.3 OTHER DEVELOPMENTS 201 15 COMPANY PROFILES 202 15.1 KEY PLAYERS 202 15.1.1 MICROSOFT 202 15.1.1.1 Business overview 202 15.1.1.2 Products/Services offered 203 15.1.1.3 Recent developments 204 15.1.1.3.1 Deals 204 15.1.1.4 MnM view 204 15.1.1.4.1 Key strengths 204 15.1.1.4.2 Strategic choices 204 15.1.1.4.3 Weaknesses & competitive threats 204 15.1.2 SIEMENS HEALTHINEERS AG 205 15.1.2.1 Business overview 205 15.1.2.2 Products/Services offered 206 15.1.2.3 Recent developments 207 15.1.2.3.1 Deals 207 15.1.2.4 MnM view 207 15.1.2.4.1 Key strengths 207 15.1.2.4.2 Strategic choices 208 15.1.2.4.3 Weaknesses & competitive threats 208   15.1.3 KONINKLIJKE PHILIPS N.V. 209 15.1.3.1 Business overview 209 15.1.3.2 Products/Services offered 210 15.1.3.3 Recent developments 211 15.1.3.3.1 Deals 211 15.1.3.4 MnM view 211 15.1.3.4.1 Key strengths 211 15.1.3.4.2 Strategic choices 211 15.1.3.4.3 Weaknesses & competitive threats 211 15.1.4 DASSAULT SYSTÈMES 212 15.1.4.1 Business overview 212 15.1.4.2 Products/Services offered 213 15.1.4.3 Recent developments 214 15.1.4.3.1 Product/Service launches & enhancements 214 15.1.4.3.2 Deals 215 15.1.4.4 MnM view 216 15.1.4.4.1 Key strengths 216 15.1.4.4.2 Strategic choices 216 15.1.4.4.3 Weaknesses & competitive threats 216 15.1.5 AMAZON WEB SERVICES, INC. 217 15.1.5.1 Business overview 217 15.1.5.2 Products/Services offered 218 15.1.5.3 Recent developments 219 15.1.5.3.1 Product/Service launches & enhancements 219 15.1.5.3.2 Deals 219 15.1.5.4 MnM view 219 15.1.5.4.1 Key strengths 219 15.1.5.4.2 Strategic choices 220 15.1.5.4.3 Weaknesses & competitive threats 220 15.1.6 GE HEALTHCARE 221 15.1.6.1 Business overview 221 15.1.6.2 Products/Services offered 222 15.1.6.3 Recent developments 223 15.1.6.3.1 Deals 223 15.1.7 ORACLE 224 15.1.7.1 Business overview 224 15.1.7.2 Products/Services offered 225 15.1.7.3 Recent developments 226 15.1.7.3.1 Deals 226   15.1.8 IBM 227 15.1.8.1 Business overview 227 15.1.8.2 Products/Services offered 228 15.1.8.3 Recent developments 229 15.1.8.3.1 Deals 229 15.1.9 PTC 230 15.1.9.1 Business overview 230 15.1.9.2 Products/Services offered 231 15.1.9.3 Recent developments 232 15.1.9.3.1 Deals 232 15.1.10 SAP 233 15.1.10.1 Business overview 233 15.1.10.2 Products/Services offered 234 15.1.10.3 Recent developments 235 15.1.10.3.1 Deals 235 15.1.10.3.2 Other developments 235 15.1.11 ATOS SE 236 15.1.11.1 Business overview 236 15.1.11.2 Products/Services offered 237 15.1.11.3 Recent developments 237 15.1.11.3.1 Deals 237 15.1.12 NVIDIA CORPORATION 238 15.1.12.1 Business overview 238 15.1.12.2 Products/Services offered 239 15.1.12.3 Recent developments 240 15.1.12.3.1 Product/Service launches & enhancements 240 15.1.12.3.2 Deals 240 15.1.13 ANSYS INC. 241 15.1.13.1 Business overview 241 15.1.13.2 Products/Services offered 242 15.1.13.3 Recent developments 243 15.1.13.3.1 Product/Service launches & enhancements 243 15.1.13.3.2 Deals 243 15.1.14 FASTSTREAM TECHNOLOGIES 244 15.1.14.1 Business overview 244 15.1.14.2 Products/Services offered 244 15.1.15 RESCALE, INC. 245 15.1.15.1 Business overview 245 15.1.15.2 Products/Services offered 245 15.1.15.2.1 Other developments 246   15.2 OTHER PLAYERS 247 15.2.1 TWIN HEALTH 247 15.2.2 VERTO HEALTH 248 15.2.3 QBIO 249 15.2.4 THOUGHTWIRE 250 15.2.5 SIM&CURE 251 15.2.6 OWKIN, INC 252 15.2.7 NUREA 253 15.2.8 UNLEARN.AI, INC. 254 15.2.9 VIRTONOMY GMBH 255 15.2.10 PREDISURGE 256 16 RESEARCH METHODOLOGY 257 16.1 RESEARCH APPROACH 257 16.1.1 SECONDARY RESEARCH 257 16.1.1.1 Key data from secondary sources 258 16.1.2 PRIMARY RESEARCH 258 16.1.2.1 Key data from primary sources 260 16.1.2.2 Breakdown of primaries 260 16.1.2.3 Insights from primary experts 261 16.2 RESEARCH METHODOLOGY DESIGN 261 16.3 MARKET SIZE ESTIMATION 262 16.4 MARKET BREAKDOWN DATA TRIANGULATION 266 16.5 MARKET SHARE ESTIMATION 267 16.6 STUDY ASSUMPTIONS 267 16.7 RESEARCH LIMITATIONS 268 16.7.1 METHODOLOGY-RELATED LIMITATIONS 268 16.7.2 SCOPE-RELATED LIMITATIONS 268 16.8 RISK ASSESSMENT 268 17 APPENDIX 269 17.1 DISCUSSION GUIDE 269 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 271 17.3 CUSTOMIZATION OPTIONS 273 17.4 RELATED REPORTS 273 17.5 AUTHOR DETAILS 274
圖表清單 List of Tables & Figures
TABLE 1 DIGITAL TWINS IN HEALTHCARE MARKET: INCLUSIONS & EXCLUSIONS 28 TABLE 2 DIGITAL TWINS IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 47 TABLE 3 DIGITAL TWIN IN HEALTHCARE MARKET: ROLE IN ECOSYSTEM 52 TABLE 4 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY TYPE (2025) 53 TABLE 5 INDICATIVE PRICE FOR DIGITAL TWIN IN HEALTHCARE MARKET, BY REGION (2025) 54 TABLE 6 DIGITAL TWIN IN HEALTHCARE: KEY CONFERENCES & EVENTS, 2026–2027 55 TABLE 7 CASE 1: UNLEARN.AI – DIGITAL TWIN SYNTHETIC CONTROL ARMS IN ALS CLINICAL TRIALS 57 TABLE 8 CASE 2: TWIN HEALTH – WHOLE BODY DIGITAL TWIN FOR TYPE 2 DIABETES REMISSION 57 TABLE 9 CASE 3: INHEART/PREDISURGE – AI-POWERED CARDIAC DIGITAL TWIN FOR SURGICAL PLANNING 58 TABLE 10 US ADJUSTED RECIPROCAL TARIFF RATES 59 TABLE 11 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR DIGITAL TWIN IN HEALTHCARE MARKET 68 TABLE 12 DIGITAL TWIN IN HEALTHCARE MARKET: LIST OF PATENTS/PATENT APPLICATIONS 69 TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79 TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80 TABLE 18 REGULATORY SCENARIO IN NORTH AMERICA 80 TABLE 19 REGULATORY SCENARIO IN EUROPE 81 TABLE 20 REGULATORY SCENARIO IN ASIA PACIFIC 81 TABLE 21 REGULATORY SCENARIO IN LATIN AMERICA 82 TABLE 22 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 82 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS (%) 85 TABLE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS 86 TABLE 25 UNMET NEEDS IN DIGITAL TWIN IN HEALTHCARE MARKET 88 TABLE 26 END USER EXPECTATIONS IN DIGITAL TWIN IN HEALTHCARE MARKET 89 TABLE 27 DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 92 TABLE 28 DIGITAL TWINS IN HEALTHCARE SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 93 TABLE 29 KEY SOFTWARE SOLUTIONS OFFERED BY PLAYERS 94 TABLE 30 DIGITAL TWINS IN HEALTHCARE SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 94 TABLE 31 DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 96 TABLE 32 PROCESS TWINS OFFERED BY MARKET PLAYERS 96 TABLE 33 DIGITAL TWINS IN HEALTHCARE MARKET FOR PROCESS TWINS, BY REGION, 2024–2031 (USD MILLION) 97 TABLE 34 SYSTEM TWINS OFFERED BY MARKET PLAYERS 97 TABLE 35 DIGITAL TWINS IN HEALTHCARE MARKET FOR SYSTEM TWINS, BY REGION, 2024–2031 (USD MILLION) 98 TABLE 36 WHOLE BODY TWINS OFFERED BY MARKET PLAYERS 98 TABLE 37 DIGITAL TWINS IN HEALTHCARE MARKET FOR WHOLE BODY TWINS, BY REGION, 2024–2031 (USD MILLION) 99 TABLE 38 BODY PART TWINS OFFERED BY PLAYERS 100 TABLE 39 DIGITAL TWINS IN HEALTHCARE MARKET FOR BODY PART TWINS, BY REGION, 2024–2031 (USD MILLION) 100 TABLE 40 DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 102 TABLE 41 DIGITAL TWINS IN HEALTHCARE MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 103 TABLE 42 DIGITAL TWINS IN HEALTHCARE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2024–2031 (USD MILLION) 104 TABLE 43 DIGITAL TWINS IN HEALTHCARE MARKET FOR SURGICAL PLANNING & MEDICAL EDUCATION, BY REGION, 2024–2031 (USD MILLION) 105 TABLE 44 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE DESIGN & TESTING, BY COUNTRY, 2024–2031 (USD MILLION) 106 TABLE 45 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE WORKFLOW OPTIMIZATION & ASSET MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 107 TABLE 46 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 108 TABLE 47 DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 110 TABLE 48 DIGITAL TWINS IN HEALTHCARE MARKET FOR PHARMA & BIOPHARMA COMPANIES, BY REGION, 2024–2031 (USD MILLION) 111 TABLE 49 DIGITAL TWINS IN HEALTHCARE MARKET FOR RESEARCH & ACADEMIA, BY REGION, 2024–2031 (USD MILLION) 112 TABLE 50 DIGITAL TWINS IN HEALTHCARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2024–2031 (USD MILLION) 113 TABLE 51 DIGITAL TWINS IN HEALTHCARE MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2024–2031 (USD MILLION) 114 TABLE 52 DIGITAL TWINS IN HEALTHCARE MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 115 TABLE 53 DIGITAL TWINS IN HEALTHCARE MARKET, BY REGION, 2024–2031 (USD MILLION) 117 TABLE 54 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 55 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 119 TABLE 56 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 119 TABLE 57 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 120 TABLE 58 NORTH AMERICA: DIGITAL TWINS IN MARKET, BY END USER, 2024–2031 (USD MILLION) 120 TABLE 59 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 122 TABLE 60 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 122 TABLE 61 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 122 TABLE 62 US: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 123 TABLE 63 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 124 TABLE 64 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 124 TABLE 65 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 125 TABLE 66 CANADA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 125 TABLE 67 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126 TABLE 68 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 126 TABLE 69 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 127 TABLE 70 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 127 TABLE 71 EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 128 TABLE 72 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 129 TABLE 73 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 129 TABLE 74 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 130 TABLE 75 GERMANY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 130 TABLE 76 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 131 TABLE 77 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 78 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 132 TABLE 79 UK: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 132 TABLE 80 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 133 TABLE 81 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 134 TABLE 82 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 134 TABLE 83 FRANCE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 135 TABLE 84 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 136 TABLE 85 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 136 TABLE 86 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 136 TABLE 87 ITALY: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 137 TABLE 88 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 137 TABLE 89 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 138 TABLE 90 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 138 TABLE 91 SPAIN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 139 TABLE 92 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 140 TABLE 93 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 140 TABLE 94 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 140 TABLE 95 REST OF EUROPE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 141 TABLE 96 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 97 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 143 TABLE 98 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 99 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 144 TABLE 100 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 144 TABLE 101 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 145 TABLE 102 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 146 TABLE 103 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 146 TABLE 104 JAPAN: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 147 TABLE 105 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 148 TABLE 106 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 107 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 148 TABLE 108 CHINA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 149 TABLE 109 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 150 TABLE 110 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 150 TABLE 111 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 150 TABLE 112 INDIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 151 TABLE 113 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 152 TABLE 114 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 115 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 152 TABLE 116 AUSTRALIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 153 TABLE 117 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 154 TABLE 118 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 154 TABLE 119 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 155 TABLE 120 SOUTH KOREA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 155 TABLE 121 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 156 TABLE 122 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 156 TABLE 123 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 157 TABLE 124 REST OF ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 157 TABLE 125 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 126 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 158 TABLE 127 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 159 TABLE 128 LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 159 TABLE 129 LATIN AMERICA: DIGITAL TWINS IN MARKET, BY END USER, 2024–2031 (USD MILLION) 160 TABLE 130 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 161 TABLE 131 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 132 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 161 TABLE 133 BRAZIL: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 162 TABLE 134 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 163 TABLE 135 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 163 TABLE 136 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 163 TABLE 137 MEXICO: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 164 TABLE 138 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 165 TABLE 139 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 165 TABLE 140 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 165 TABLE 141 REST OF LATIN AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 166 TABLE 142 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 143 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 167 TABLE 144 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 168 TABLE 145 MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 168 TABLE 146 MIDDLE EAST & AFRICA: DIGITAL TWINS IN MARKET, BY END USER, 2024–2031 (USD MILLION) 169 TABLE 147 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 148 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 170 TABLE 149 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 170 TABLE 150 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 171 TABLE 151 GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 171 TABLE 152 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 172 TABLE 153 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 172 TABLE 154 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 173 TABLE 155 SAUDI ARABIA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 173 TABLE 156 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 174 TABLE 157 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 174 TABLE 158 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 175 TABLE 159 UAE: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 175 TABLE 160 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 176 TABLE 161 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 176 TABLE 162 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 177 TABLE 163 OTHER GCC COUNTRIES: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 177 TABLE 164 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 178 TABLE 165 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 166 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 179 TABLE 167 SOUTH AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 179 TABLE 168 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 180 TABLE 169 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY TYPE, 2024–2031 (USD MILLION) 180 TABLE 170 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 181 TABLE 171 REST OF MIDDLE EAST & AFRICA: DIGITAL TWINS IN HEALTHCARE MARKET, BY END USER, 2024–2031 (USD MILLION) 181 TABLE 172 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE MARKET, JANUARY 2023–MAY 2026 182 TABLE 173 DIGITAL TWINS IN HEALTHCARE MARKET: DEGREE OF COMPETITION 186 TABLE 174 DIGITAL TWIN IN HEALTHCARE MARKET: REGION FOOTPRINT (15 COMPANIES) 192 TABLE 175 DIGITAL TWIN IN HEALTHCARE MARKET: COMPONENT FOOTPRINT (15 COMPANIES) 193 TABLE 176 DIGITAL TWIN IN HEALTHCARE MARKET: TYPE FOOTPRINT (15 COMPANIES) 194 TABLE 177 DIGITAL TWIN IN HEALTHCARE MARKET: APPLICATION FOOTPRINT (15 COMPANIES) 194 TABLE 178 DIGITAL TWIN IN HEALTHCARE MARKET: END USER FOOTPRINT (15 COMPANIES) 195 TABLE 179 DIGITAL TWINS IN HEALTHCARE MARKET: PRODUCT/SERVICE LAUNCHES, ENHANCEMENTS, AND APPROVALS, JANUARY 2023–MAY 2026 199 TABLE 180 DIGITAL TWINS IN HEALTHCARE MARKET: DEALS, JANUARY 2023–MAY 2026 200 TABLE 181 DIGITAL TWINS IN HEALTHCARE MARKET: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 201 TABLE 182 MICROSOFT: COMPANY OVERVIEW 202 TABLE 183 MICROSOFT CORPORATION: PRODUCTS/SERVICES OFFERED 203 TABLE 184 MICROSOFT: DEALS, JANUARY 2023–MAY 2026 204 TABLE 185 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 205 TABLE 186 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 206 TABLE 187 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023–MAY 2026 207 TABLE 188 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 209 TABLE 189 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED 210 TABLE 190 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–MAY 2026 211 TABLE 191 DASSAULT SYSTÈMES: COMPANY OVERVIEW 212 TABLE 192 DASSAULT SYSTÈMES: PRODUCTS/SERVICES OFFERED 213 TABLE 193 DASSAULT SYSTÈMES: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2023–MAY 2026 214 TABLE 194 DASSAULT SYSTÈMES: DEALS, JANUARY 2023–MAY 2026 215 TABLE 195 AMAZON WEB SERVICES, INC.: COMPANY OVERVIEW 217 TABLE 196 AMAZON WEB SERVICES, INC.: PRODUCTS/SERVICES OFFERED 218 TABLE 197 AMAZON WEB SERVICES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2023–MAY 2026 219 TABLE 198 AMAZON WEB SERVICES, INC.: DEALS, JANUARY 2023–MAY 2026 219 TABLE 199 GE HEALTHCARE: COMPANY OVERVIEW 221 TABLE 200 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 222 TABLE 201 GE HEALTHCARE: DEALS, JANUARY 2023–MAY 2026 223 TABLE 202 ORACLE: COMPANY OVERVIEW 224 TABLE 203 ORACLE: PRODUCTS/SERVICES OFFERED 225 TABLE 204 ORACLE: DEALS, JANUARY 2023–MAY 2026 226 TABLE 205 IBM: COMPANY OVERVIEW 227 TABLE 206 IBM: PRODUCTS/SERVICES OFFERED 228 TABLE 207 IBM: DEALS, JANUARY 2023–MAY 2026 229 TABLE 208 PTC: COMPANY OVERVIEW 230 TABLE 209 PTC: PRODUCTS/SERVICES OFFERED 231 TABLE 210 PTC: DEALS, JANUARY 2023–MAY 2026 232 TABLE 211 SAP: COMPANY OVERVIEW 233 TABLE 212 SAP: PRODUCTS/SERVICES OFFERED 234 TABLE 213 SAP: DEALS, JANUARY 2023–MAY 2026 235 TABLE 214 SAP: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 235 TABLE 215 ATOS SE: COMPANY OVERVIEW 236 TABLE 216 ATOS SE: PRODUCTS/SERVICES OFFERED 237 TABLE 217 ATOS SE: DEALS, JANUARY 2023–MAY 2026 237 TABLE 218 NVIDIA CORPORATION: COMPANY OVERVIEW 238 TABLE 219 NVIDIA CORPORATION: PRODUCTS/SERVICES OFFERED 239 TABLE 220 NVIDIA CORPORATION: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2023–MAY 2026 240 TABLE 221 NVIDIA CORPORATION: DEALS, JANUARY 2023–MAY 2026 240 TABLE 222 ANSYS INC.: COMPANY OVERVIEW 241 TABLE 223 ANSYS INC.: PRODUCTS/SERVICES OFFERED 242 TABLE 224 ANSYS INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2023–MAY 2026 243 TABLE 225 ANSYS INC.: DEALS, JANUARY 2023–MAY 2026 243 TABLE 226 FASTSTREAM TECHNOLOGIES: COMPANY OVERVIEW 244 TABLE 227 FASTSTREAM TECHNOLOGIES: PRODUCTS/SERVICES OFFERED 244 TABLE 228 RESCALE, INC.: COMPANY OVERVIEW 245 TABLE 229 RESCALE, INC.: PRODUCTS/SERVICES OFFERED 245 TABLE 230 RESCALE, INC.: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 246 TABLE 231 TWIN HEALTH: COMPANY OVERVIEW 247 TABLE 232 VERTO HEALTH: COMPANY OVERVIEW 248 TABLE 233 QBIO: COMPANY OVERVIEW 249 TABLE 234 THOUGHTWIRE: COMPANY OVERVIEW 250 TABLE 235 SIM&CURE: COMPANY OVERVIEW 251 TABLE 236 OWKIN, INC: COMPANY OVERVIEW 252 TABLE 237 NUREA: COMPANY OVERVIEW 253 TABLE 238 UNLEARN.AI, INC.: COMPANY OVERVIEW 254 TABLE 239 VIRTONOMY GMBH: COMPANY OVERVIEW 255 TABLE 240 PREDISURGE: COMPANY OVERVIEW 256 TABLE 241 DIGITAL TWINS IN HEALTHCARE MARKET: RISK ASSESSMENT 268 FIGURE 1 DIGITAL TWINS IN HEALTHCARE MARKET SEGMENTATION & REGIONAL SCOPE 28 FIGURE 2 DIGITAL TWINS IN HEALTHCARE MARKET: YEARS CONSIDERED 29 FIGURE 3 MARKET SCENARIO 31 FIGURE 4 GLOBAL DIGITAL TWINS IN HEALTHCARE MARKET, 2024–2031 32 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DIGITAL TWIN IN HEALTHCARE MARKET, 2023–2026 32 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF DIGITAL TWIN IN HEALTHCARE MARKET 33 FIGURE 7 HIGH-GROWTH SEGMENTS IN DIGITAL TWIN IN HEALTHCARE MARKET, 2026–2031 34 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN DIGITAL TWIN IN HEALTHCARE MARKET DURING FORECAST PERIOD 35 FIGURE 9 INCREASING USE OF DIGITAL TWINS AND GROWING IMPORTANCE OF PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH 36 FIGURE 10 SOFTWARE ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2025 37 FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 37 FIGURE 12 DIGITAL TWIN IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS 46 FIGURE 13 DIGITAL TWIN IN MARKET: VALUE CHAIN ANALYSIS (2025) 50 FIGURE 14 DIGITAL TWIN IN HEALTHCARE MARKET: ECOSYSTEM ANALYSIS 52 FIGURE 15 REVENUE SHIFT IN DIGITAL TWIN IN HEALTHCARE MARKET 56 FIGURE 16 RECENT FUNDING OF PLAYERS IN DIGITAL TWIN IN HEALTHCARE MARKET 56 FIGURE 17 PATENT PUBLICATION TRENDS IN DIGITAL TWIN IN HEALTHCARE MARKET, 2015–2026 68 FIGURE 18 JURISDICTION AND TOP APPLICANT ANALYSIS FOR DIGITAL TWIN IN HEALTHCARE MARKET 68 FIGURE 19 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR DIGITAL TWIN IN HEALTHCARE MARKET (JANUARY 2015 TO FEBRUARY 2026) 69 FIGURE 20 MARKET POTENTIAL OF AI/GEN AI ON DIGITAL TWIN IN HEALTHCARE ACROSS INDUSTRIES 72 FIGURE 21 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 74 FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS 85 FIGURE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS 86 FIGURE 24 NORTH AMERICA: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 118 FIGURE 25 ASIA PACIFIC: DIGITAL TWINS IN HEALTHCARE MARKET SNAPSHOT 142 FIGURE 26 DIGITAL TWIN IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS 185 FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIGITAL TWINS IN HEALTHCARE (2025) 186 FIGURE 28 DIGITAL TWIN IN HEALTHCARE MARKET: BRAND COMPARATIVE ANALYSIS 188 FIGURE 29 EV/EBITDA OF KEY VENDORS 189 FIGURE 30 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 189 FIGURE 31 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 191 FIGURE 32 DIGITAL TWIN IN HEALTHCARE MARKET: COMPANY FOOTPRINT 192 FIGURE 33 DIGITAL TWINS IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 197 FIGURE 34 MICROSOFT: COMPANY SNAPSHOT (2025) 203 FIGURE 35 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 206 FIGURE 36 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 210 FIGURE 37 DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2025) 213 FIGURE 38 AMAZON WEB SERVICES, INC.: COMPANY SNAPSHOT (2025) 218 FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 222 FIGURE 40 ORACLE: COMPANY SNAPSHOT (2024) 225 FIGURE 41 IBM: COMPANY SNAPSHOT (2025) 228 FIGURE 42 PTC: COMPANY SNAPSHOT (2025) 231 FIGURE 43 SAP: COMPANY SNAPSHOT (2025) 234 FIGURE 44 ATOS SE: COMPANY SNAPSHOT (2025) 236 FIGURE 45 NVIDIA CORPORATION: COMPANY SNAPSHOT (2025) 239 FIGURE 46 ANSYS INC. (SYNOPSYS, INC.): COMPANY SNAPSHOT (2025) 242 FIGURE 47 RESEARCH DESIGN 257 FIGURE 48 PRIMARY SOURCES 259 FIGURE 49 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 260 FIGURE 50 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 262 FIGURE 51 BOTTOM-UP APPROACH 263 FIGURE 52 TOP-DOWN APPROACH 263 FIGURE 53 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS 264 FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 265 FIGURE 55 DIGITAL TWINS IN HEALTHCARE MARKET: DATA TRIANGULATION 266

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們